Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Mazzo David J Create: Alert

All | News | Filings
Date FiledTypeDescription
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,030 shares @ $3.2, valued at $3.3k
01/11/2023 4 Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.
Txns: Granted 60,000 shares @ $0
Paid exercise price by delivering 7,845 shares @ $3, valued at $23.5k
Paid exercise price by delivering 3,470 shares @ $3.195, valued at $11.1k
Granted 30,000 options to buy @ $3, valued at $90k
01/18/2022 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Paid exercise price by delivering 6,471 shares @ $0.8063, valued at $5.2k
Paid exercise price by delivering 6,611 shares @ $0.8204, valued at $5.4k
01/12/2022 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 401,000 shares @ $0
Paid exercise price by delivering 56,410 shares @ $0.917, valued at $51.7k
Paid exercise price by delivering 16,740 shares @ $0.8651, valued at $14.5k
Granted 200,000 options to buy @ $0.917, valued at $183.4k
04/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 Mazzo David J (Director) has filed a Form 4 on Seneca Biopharma, Inc.
Txns: Granted 6,000 options to buy @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2020 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 46,000 shares @ $0
Paid exercise price by delivering 6,246 shares @ $3.28, valued at $20.5k
Paid exercise price by delivering 6,382 shares @ $3.38, valued at $21.6k
Granted 69,000 options to buy @ $3.28, valued at $226.3k
01/09/2020 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Paid exercise price by delivering 4,522 shares @ $2.83, valued at $12.8k
10/11/2019 4/A Mazzo David J (Director) has filed a Form 4 on Neuralstem, Inc.
Txns: Granted 10,106 options to buy @ $0
10/11/2019 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 33,333 options to buy @ $1.95, valued at $65k
09/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2019 4 Mazzo David J (Director) has filed a Form 4 on Neuralstem, Inc.
Txns: Granted 187,510 options to buy @ $0.3001, valued at $56.3k
06/27/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2019 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 20,000 options to buy @ $1.77, valued at $35.4k
01/16/2019 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 47,000 shares @ $0
Paid exercise price by delivering 6,301 shares @ $0
Granted 71,000 options to buy @ $4.95, valued at $351.5k
01/10/2019 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Paid exercise price by delivering 4,478 shares @ $4.64, valued at $20.8k
09/10/2018 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 1,667 options to buy @ $2.32, valued at $3.9k
Granted 417 restricted stock units @ $0
06/29/2018 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 17,500 restricted stock units @ $0
06/26/2018 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Granted 33,333 options to buy @ $1.95, valued at $65k
Granted 8,333 restricted stock units @ $0
06/21/2018 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 33,300 shares @ $8.64, valued at $287.7k
Paid exercise price by delivering 16,091 shares @ $8.64, valued at $139k
04/24/2018 4 Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.
Txns: Exercised 120,000 options to buy @ $1.13, valued at $135.6k
04/10/2018 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 33,300 options to buy @ $0
01/10/2018 4 Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns: Granted 33,300 shares @ $0
Paid exercise price by delivering 4,462 shares @ $0
Granted 50,000 options @ $3.79, valued at $189.5k
12/19/2017 4 Mazzo David J (Director) has filed a Form 4 on pSivida Corp.
Txns: Granted 20,000 options to buy @ $1.77, valued at $35.4k
Granted 17,500 restricted stock units @ $0
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy